rxstatShortages › Lactate Dextrose Magnesium Chloride

Lactate Dextrose Magnesium Chloride (Dianeal Pd4 Capd, Dianeal Pd) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Aug 10, 2026

Some Lactate Dextrose Magnesium Chloride products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 12, 2026.
Products affected
2 / 6
In shortage since
Aug 4, 2026
Est. full return
Aug 12, 2026
Reports on file
14
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 18.3MG 538MG 1.5G 5.08MG · SOLUTION · VANTIVE ULC
DIN 00865095 · since Aug 6, 2026, est. end Aug 12, 2026 · Delay in Production
Active shortage
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 18.3MG 538MG 1.5G 5.08MG · SOLUTION · VANTIVE ULC
DIN 00865095 · since Aug 4, 2026, est. end Aug 12, 2026 · Delay in Production
Active shortage
DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM
538MG 2.5G 5.08MG 18.3MG 448MG · SOLUTION · VANTIVE ULC
DIN 00865109 · since Aug 4, 2026, est. end Aug 12, 2026 · Delay in production
Discontinued
DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE
392MG 1.5G 15.2MG 23.9MG 567MG · LIQUID · BAXTER CORPORATION
DIN 00799815
Discontinued
DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 2.5G 5.08MG 18.3MG 538MG · SOLUTION · BAXTER CORPORATION
DIN 00865109
Discontinued
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 1.5G 5.08MG 18.3MG 538MG · SOLUTION · BAXTER CORPORATION
DIN 00865095
Discontinued
DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE
392MG 2.5G 15.2MG 23.9MG 567MG · SOLUTION · BAXTER CORPORATION
DIN 00799823
Resolved
DIANEAL PD 101 CAPD SOLUTION W 0.5% DEXTROSE
392MG 500MG 15.2MG 23.9MG 567MG · SOLUTION · BAXTER CORPORATION
DIN 00799793 · ended Aug 1, 2019 · Disruption of the manufacture of the drug.
Resolved
DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 4.25G 5.08MG 18.3MG 538MG · SOLUTION · BAXTER CORPORATION
DIN 00865117 · ended Apr 29, 2019 · Disruption of the manufacture of the drug.
Resolved
DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE
392MG 2.5G 15.2MG 23.9MG 567MG · SOLUTION · BAXTER CORPORATION
DIN 00799823 · ended Feb 25, 2019 · Disruption of the manufacture of the drug.
Resolved
DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 2.5G 5.08MG 18.3MG 538MG · SOLUTION · BAXTER CORPORATION
DIN 00865109 · ended Feb 8, 2018 · Shortage of an inactive ingredient or component.
Resolved
DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM
448MG 1.5G 5.08MG 18.3MG 538MG · SOLUTION · BAXTER CORPORATION
DIN 00865095 · ended Feb 6, 2018 · Shortage of an inactive ingredient or component.

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Lactate Dextrose Magnesium Chloride is currently affected by 2 active shortage reports filed with Health Canada by VANTIVE ULC.

The reported causes are: delay in production; delay in production. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lactate Dextrose Magnesium Chloride is classified under “HEMODIALYTICS AND HEMOFILTRATES” (ATC B05ZA).

Recent changes

Common questions

When will Lactate Dextrose Magnesium Chloride be back in stock in Canada?

The latest manufacturer estimate is Aug 12, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Lactate Dextrose Magnesium Chloride in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (hemodialytics and hemofiltrates)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.